Orbis Medicines
48 employees on LinkedIn · 1 known investors
Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets. It uses a proprietary chemistry and machine-learning platform to systematically explore macrocycle chemical space and generate optimized drug candidates.
Investors · 1
Frequently asked questions
- What does Orbis Medicines do?
- Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets. It uses a proprietary chemistry and machine-learning platform to systematically explore macrocycle chemical space and generate optimized drug candidates.
- Who are Orbis Medicines's investors?
- Orbis Medicines's investors include New Enterprise Associates (NEA).